Last updated on July 2019

Prevalence of Severe Asthma in Spanish Hospitals


Brief description of study

Asthma is a chronic disease. Prevalence of asthma in 2014 among Spanish population was 5%, of which 10% were diagnosed with severe asthma. According to Spanish National Guideline for the Management of Asthma (GEMA) 4.1 criteria, asthma can be classified according to its severity (intermittent, mild persistent, moderate persistent or severe persistent) or level of asthma control (controlled, partly controlled or uncontrolled). This Guideline describes that only 1 in 10 subjects with severe asthma is well controlled, meaning that there is a 90% prevalence of non-controlled severe asthma.

This prospective, non-interventional, observational, multicenter and case-control study aims to assess the prevalence of severe asthma in Spanish Hospitals. The study will describe the characteristics of severe versus non-severe asthmatic subjects, assess their eligibility to receive biological treatments approved for this disease, resource consumption and evaluate the most prevalent phenotypes of severe asthma in Spain. Enrolled subjects will be divided into two cohorts, based on asthma severity according to the Global Initiative for Asthma (GINA) and the International European Respiratory Society (ERS)/American Thoracic Society (ATS) Guidelines. Cohort A: subjects diagnosed of severe asthma and Cohort B: subjects with non-severe asthma. Approximately 320 severe asthmatic subjects and 160 non-severe asthmatic subjects will be enrolled in the study. A software of big data will be used to do a sub study for comparing the results obtained through this software tool against results obtained through Gold standard classical methods used in this prospective observational study (the descriptive assessment of severe asthma prevalence and the prospective evolution of subjects).

Clinical Study Identifier: NCT03137043

Find a site near you

Start Over

GSK Investigational Site

L'Hospitalet de Llobregat, Spain
  Connect »

GSK Investigational Site

La Laguna-Tenerife, Spain
  Connect »

GSK Investigational Site

Majadahonda (Madrid), Spain
  Connect »

GSK Investigational Site

Manresa (Barcelona), Spain
  Connect »

GSK Investigational Site

Ponferrada (León), Spain
  Connect »

GSK Investigational Site

Sagunto/Valencia, Spain
  Connect »

GSK Investigational Site

Santiago de Compostela, Spain
  Connect »

GSK Investigational Site

Valdemoro/Madrid, Spain
  Connect »

GSK Investigational Site

Xátiva-Valencia, Spain
  Connect »

GSK Investigational Site

Ponferrada (León), Spain
  Connect »

GSK Investigational Site

Xátiva-Valencia, Spain
  Connect »